Browse
Submit Data
Databases
API
Help

Dataset Information

11 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-[2-(Trifluoro-meth-yl)phen-yl]-2H-1-benzopyran-4(3H)-one.

ABSTRACT: In the title compound, C(16)H(11)F(3)O(2), the ?-pyran-one ring adopts an envelope conformation with the chiral C atom standing out of the ring plane. In the crystal, molecules are linked by C-H?O and C-H?F inter-actions.

SUBMITTER: Francuski BM

PROVIDER: S-EPMC3344626 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

2-[2-(Trifluoro-meth-yl)phen-yl]-2H-1-benzopyran-4(3H)-one.

Francuski Bojana M BM Ivković Branka B Stojanović Ivana I Vladimirov Sote S Francuski Djordje D

Acta crystallographica. Section E, Structure reports online 20120425 Pt 5

In the title compound, C(16)H(11)F(3)O(2), the γ-pyran-one ring adopts an envelope conformation with the chiral C atom standing out of the ring plane. In the crystal, molecules are linked by C-H⋯O and C-H⋯F inter-actions. ...[more]

PMID: 22590388

Similar Datasets

4-[3-(Trifluoro-meth-yl)phen-yl]-5,6,7,8-tetra-hydro-cinnolin-3(2H)-one.

Project description:The title compound, C(15)H(13)F(3)N(2)O, contains one benzene ring, one cyclo-hexane ring and a pyridazine ring. The dihedral angle formed by the pyridazine ring with the benzene ring is 61.5?(2)°. The crystal structure is stabilized by two inter-molecular hydrogen bonds (N-H?O and C-H?F). The cyclohexane ring adopts a screw-boat conformation. The CF(3) group is disordered over two positions; the site occupancy factors are ca 0.6 and 0.4.

| S-EPMC2960356 | biostudies-literature

6-Methyl-2-p-tolyl-4-[3-(trifluoro-meth-yl)phen-yl]pyridazin-3(2H)-one.

Project description:In the title mol-ecule, C(19)H(15)F(3)N(2)O, the benzene rings of the tolyl and trifluoro-methyl-phenyl groups form dihedral angles of 64.1?(2) and 38.5?(2)°, respectively, with the pyridazine ring. The CF(3) group is disordered over two orientations, with site-occupancy factors of ca 0.56 and 0.44.

| S-EPMC2961053 | biostudies-literature

2-Phenyl-5-(trifluoro-meth-yl)pyrazol-3(2H)-one.

Project description:The title compound, C(10)H(7)F(3)N(2)O, is an analogue of pyrazolone derivatives with potential analgesic and anti-inflammatory properties. Its mol-ecular structure consists of phenyl and pyrazol-3(2H)-one units with a dihedral angle between the mean planes of the rings of 33.0?(1)°. The crystal structure is stabilized by an inter-molecular hydrogen bond between the N-H group and the carbonyl O atom of the pyrazol-3(2H)-one ring which links the mol-ecules into supra-molecular C(5) chains along [001] and by weak ?-? stacking inter-actions between the phenyl rings [centroid-centroid distance = 3.881?(2)?Å]. The F atoms are disordered over two positions with refined site occupancies of 0.768(11) and 0.232(11).

| S-EPMC2977152 | biostudies-literature

2-(4-Fluoro-phen-yl)-2H-chromen-4(3H)-one.

Project description:In the crystal structure of the title compound, C(15)H(11)FO(2), mol-ecules form inversion dimers through pairs of weak C-H⋯O hydrogen bonds. Dimers oriented in parallel, linked by C-H⋯π contacts, are arranged in columns along the b axis. The fluoro-phenyl ring and the benzene ring of the 2H-chromen-4(3H)-one unit are inclined to one another by 70.41 (16)°. They are respectively parallel in a given column or almost perpendicular [oriented at an angle of 87.8 (1)°] in neighbouring (inversely oriented) columns, forming a herringbone pattern.

| S-EPMC3274947 | biostudies-literature

1-(Pyridin-2-yl)-2-[2-(trifluoro-meth-yl)benz-yl]-3-[2-(trifluoro-meth-yl)phen-yl]propan-1-one.

Project description:The title compound, C(23)H(17)F(6)NO, crystallizes with two mol-ecules in the asymmetric unit. The mol-ecules assume an approximate propellar shape, with the three aromatic rings being bent with respect to the plane formed by the C atoms that are connected to the methine C atom [dihedral angles: pyridyl 67.49?(3)°, phenyl 56.82?(4)° and phenyl 77.21?(6)° in one mol-ecule, and corresponding angles of 71.60?(6), 53.68?(4) and 77.53?(6)° in the second mol-ecule].

| S-EPMC3297303 | biostudies-literature

1-Phenyl-5-[4-(trifluoro-meth-yl)phen-yl]-pyrazolidin-3-one monohydrate.

Project description:In the mol-ecule of the title compound, C(16)H(13)F(3)N(2)O·H(2)O, the two benzene rings are oriented at a dihedral angle of 82.55?(3)° and the pyrazole ring adopts an envelope conformation. In the crystal structure, inter-molecular C-H?F hydrogen bonds link the mol-ecules into chains.

| S-EPMC2959759 | biostudies-literature

1-(4-Amino-phen-yl)-3-[2-(trifluoro-meth-yl)phen-yl]prop-2-en-1-one.

Project description:The title compound, C(16)H(12)F(3)NO, a derivative of biologically active chalcones, comprises two benzene rings and a central -CH=CH-C(=O)- unit. The dihedral angle between the two rings is 10.9?(1)° and the mol-ecule adopts an E configuration about the central olefinic bond. The crystal structure is stabilized by inter-molecular N-H?O and N-H?N hydrogen bonds.

| S-EPMC2979023 | biostudies-literature

2-Hy-droxy-2-trifluoro-methyl-3,4-dihydro-2H-1-benzopyran-4-one.

Project description:The heterocyclic ring in the title compound, C(10)H(7)F(3)O(3), has a half-boat conformation with the hy-droxy-bearing C atom lying 0.595?(3)?Å out of the plane of the five remaining atoms (r.m.s. deviation = 0.022?Å) in the direction of the hy-droxy O atom. Linear supra-molecular chains along the a axis, sustained by O-H?O hydrogen bonds between the hy-droxy H and ketone O atoms, feature in the crystal packing. These chains are connected into a three-dimensional architecture by C-H?O and C-H?F contacts.

| S-EPMC3394075 | biostudies-literature

3-(2-Amino-eth-yl)-2-[4-(trifluoro-meth-oxy)anilino]quinazolin-4(3H)-one.

Project description:In the title compound, C(17)H(15)F(3)N(4)O(2), the dihedral angle between the trifluoro-meth-oxy-substituted benzene ring and the pyrimidinone ring is 45.1?(5)°, while that between the fused benzene ring and the pyrimidinone ring is 0.67?(1)°. Part of one of the benzene rings and its trifluoro-meth-oxy substituent are disordered over two positions of approximately equal occupancy (0.51:0.49). Inter-molecular N-H?O and N-H?N hydrogen bonds contribute to the stability of the crystal structure. A weak intra-molecular C-H?F contact is also found. In addition, ?-? stacking inter-actions, with centroid-centroid distances in the range 3.673?(6)-3.780?(8)?Å, and weak C-H?? inter-actions are also observed.

| S-EPMC3006720 | biostudies-literature

(1E,4E)-1,5-Bis[2-(trifluoro-meth-yl)phen-yl]penta-1,4-dien-3-one.

Project description:In the title compound, C(19)H(12)F(6)O, a monoketone derivative of curcumin, both double bonds have a trans conformation. The mol-ecule is mostly planar with all C and O atoms essentially coplanar, with the exception of one benzene ring, which is tilted by 17.18?(1)° with respect to the plane of the remainder of the mol-ecule. The r.m.s. deviation from planarity of the coplanar section is 0.0097?Å. The crystal packing features weak C-H?O and C-H?F inter-actions.

| S-EPMC3569239 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data